Transparency about leadership and clinical teams Finally, we believe that patients deserve to know who is behind the platforms providing their care
The Health Benefits of Personalized GLP-1 Therapy Achieving and maintaining a healthy weight isnt just about appearanceits about improving overall health
Key Companies Innovating in GLP-1 Obesity Treatments In 2025, the landscape of obesity treatment is being reshaped by innovative companies developing GLP-1 (glucagon-like peptide-1) receptor agonists
Stimulating GLP-1R in BMSCs triggers the buildup of nuclear -catenin, which, in turn, activates osteogenic genes by binding with TCF7L12
Glycemic index, glycemic load, and dietary fiber intake of foods commonly consumed in Canada
Its not surprising, then, that results from Mercers National Survey of Employer-Sponsored Health Plans 2023 show that fewer than half of large employers (42% of those with 500 or more employees) currently cover GLP-1 medications for treatment of obesity, although another 19% say they are considering it